INT 0022
Alternative Names: INT-0022; INT0022/2010Latest Information Update: 23 Dec 2013
At a glance
- Originator IntelGenx Corp.
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bipolar disorders